Dr. Kretschmannova is the Director of Neuroscience at Melior. She has over 20 years of experience in both academic and pharmaceutical fields of research, with extensive experience in neurophysiology. She has authored or co-authored over 20 peer-reviewed articles.
Dr. Kretschmannova received her PhD in neurosciences from the Charles University in Prague, Czechia. Following her PhD, she completed post-doctoral training at the NIH, focusing on the complex interplay between function of ion channels and hormonal secretion in anterior pituitary cells, and at Tufts University, studying trafficking and targeting of GABAA receptors to the cell surface.
Prior to joining Melior Discovery in January 2023, Dr. Kretschmannova worked at PsychoGenics, Inc., where she designed and supervised client-tailored neurophysiological studies. She acquired extensive experience in neurophysiological alterations in neurodegenerative and psychiatric diseases including Alzheimer’s, Huntington’s, and Parkinson’s diseases, ALS, autism spectrum disorders and major depressive disorder.
In her free time, Karla enjoys hiking, baking, and reading mystery novels.